Literature DB >> 2166811

Involvement of nuclear factor I-binding sites in control of Akv virus gene expression.

H S Olsen1, S Lovmand, J Lovmand, P Jørgensen, N O Kjeldgaard, F S Pedersen.   

Abstract

The U3 region of Akv murine leukemia virus carries a 99-base-pair repeat that is associated with transcriptional enhancement in murine NIH 3T3 cells. Deletion analysis points to a critical function of a region within the repeat unit related to the recognition sequences for nuclear factor I proteins but distinct from the sites previously analyzed in related viruses. Nuclear proteins binding to the critical site were detected in NIH 3T3 cells and in mouse livers. A protein fraction binding to this site was purified from mouse livers by ion-exchange and DNA affinity chromatography and shown to have nuclear factor I properties. Mutations that caused a partial or complete reduction of the in vitro binding were introduced into an Akv long terminal repeat with one 99-base-pair repeat copy driving a reporter gene, and the expression activities of the mutants in NIH 3T3 cells were found to correspond to their in vitro binding activities. This correlation strongly supports the role of nuclear factor I proteins in Akv expression. Residual expression activity was, however, detected in mutants devoid of in vitro binding. This residual activity may relate to the presence of additional sequences with homology to nuclear factor I binding sites both within and outside the repeat region. The ability of these sites to bind crude and purified protein fractions with nuclear factor I activity was analyzed, and the role of the sites within and outside the repeat region for control of gene expression of Akv and related viruses is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166811      PMCID: PMC247879          DOI: 10.1128/JVI.64.9.4152-4161.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels.

Authors:  R C Switzer; C R Merril; S Shifrin
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

2.  Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.

Authors:  Y Li; E Golemis; J W Hartley; N Hopkins
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

5.  Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex.

Authors:  K Nagata; R A Guggenheimer; T Enomoto; J H Lichy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Contacts between Escherichia coli RNA polymerase and an early promoter of phage T7.

Authors:  U Siebenlist; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Nucleotide sequence of the 3' end of MCF 247 murine leukemia virus.

Authors:  M Kelly; C A Holland; M L Lung; S K Chattopadhyay; D R Lowy; N H Hopkins
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  7 in total

1.  Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.

Authors:  H L Morrison; H Y Dai; F S Pedersen; J Lenz
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.

Authors:  S Ethelberg; B Hallberg; J Lovmand; J Schmidt; A Luz; T Grundström; F S Pedersen
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.

Authors:  S C Lawrenz-Smith; A C Massey; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene.

Authors:  A Riccio; P V Pedone; L R Lund; T Olesen; H S Olsen; P A Andreasen
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

5.  B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.

Authors:  J Lovmand; A B Sorensen; J Schmidt; M Ostergaard; A Luz; F S Pedersen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation.

Authors:  A L Nielsen; N Pallisgaard; F S Pedersen; P Jørgensen
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas.

Authors:  Jinghua Liu; Annette Balle Sørensen; Bruce Wang; Matthias Wabl; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  BMC Mol Biol       Date:  2009-01-21       Impact factor: 2.946

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.